聊天GPT和心脏衰竭患者
Fotis Dimitriadis1, Stelina Alkagiet1, Lamprini Tsigkriki1
1Cardiology Department, General Hospital G. Papanikolaou, Thessaloniki, Greece.
Angiology
|March 7, 2024
概括
聊天GPT准确地回答了患者关于心力衰竭 (HF) 管理和知识的问题. 这种大型语言模型表现出强大的能力,为患者提供清晰,全面和可重复的信息.
科学领域:
- 人工智能的人工智能
- 医疗信息学 医疗信息学
- 心脏病学 心脏病学
背景情况:
- 像ChatGPT这样的大型语言模型 (LLM) 为患者教育提供了潜力.
- 准确和可访问的信息对于心力衰竭 (HF) 患者的自我管理至关重要.
- 在复杂的医疗领域评估LLM绩效是必不可少的.
研究的目的:
- 评估ChatGPT对患者关于心力衰竭 (HF) 的询问的反应的准确性和可重复性.
- 评估ChatGPT对HF知识和管理进行患者友好的解释的能力.
主要方法:
- 收集了47个关于心力衰竭 (HF) 的患者常见问题.
- 聊天GPT生成了所有记录问题的答案.
- 两个独立的研究人员评估了ChatGPT的响应的准确性和质量.
主要成果:
- 聊天GPT提供了对心力衰竭 (HF) 的准确定义,原因和危险因素.
- 该模型正确解释了诊断测试,药物和生活方式建议 (饮食,酒精,液体摄入量).
- 聊天GPT以适当的论点解决了患者对日常活动,包括工作,旅行和性健康的担忧.
结论:
- 聊天GPT在回答有关心力衰竭 (HF) 的各种患者问题方面表现非常好.
- 这项研究表明,ChatGPT作为专业,患者友好的心力衰竭护理支持工具的潜力.
- 进一步的研究应该探索将这些人工智能工具集成到临床实践中.
相关概念视频
01:26Heart Failure Drugs: Inotropic Agents
586
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
586
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
429
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
429
01:22Heart Failure Drugs: β-Blockers
338
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
338
01:22Heart Failure Drugs: Diuretics
375
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
375
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
181
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
181
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K